Here at CHEMAS, we think differently and pursue relentlessly to find next-generation drugs to cater to unmet medical needs in cancer and viral diseases.
VISION
Deliver safe and effective next-generation drugs to patients
MISSION
Develop innovative novel treatments against cancer and viral diseases
We are a pharmaceutical R&D company focusing on developing innovative drugs. In particular, our research targets discovering and developing highly effective and safe cancer and antiviral drugs. Our ultimate goal is to see patients throughout the world relieved of pain and fear of diseases and eventually recover completely without side effects or relapse.
Our original drug, CM-7919, completed preclinical and phase I clinical trials, all of which were executed according to EMA and US FDA regulation criteria. Now we are planning for cancer and COVID-19 clinical trials in Europe. Through active cooperation and partnership with global pharmaceuticals and research institutes, we will continue to research extensively on the drug’s pharmaceutical potential and keep extending our pipeline.
CHEMAS will never stop researching potential drug substances and developing innovative drugs to cater to unmet medical needs.